Skip to contentI
Imunon, Inc.
I
IMNNImunon, Inc. Q2 2024 · 10-Q
Revenue—
Net Income-$4.79M-$4.79MN/M vs Q2 2023 EPS Diluted-$7.64-$7.64N/M vs Q2 2023 Operating Income-$5,013,351N/M Operating Cash Flowderived-$4,504,633N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
Free Cash Flowderived-$4,504,633N/M ended Jun 30, 2024 · filed Aug 14, 2024 · 45 d after period end